Journal urges independent drug review board
12791
Arguing that the country&#39;s system for monitoring drug safety is haphazard and ineffectual, editors of a leading medical journal Monday called for a radical overhaul and suggested the creation of a new independent drug safety board.
723212
The system to monitor the hidden, harmful effects of widely prescribed drugs is broken. Congress should consider creating an agency independent of the Food and Drug Administration to keep watch over an industry
57674
More than 35 Enquirer readers have called or e-mailed comments about the five drugs that were criticized Thursday by an expert with the US Food and Drug Administration.
560418
The initiative is part of an effort to ferret out unpublished research consucted by pharmaceutical companies that finds medications to be ineffective or dangerous.
455038
U.S. regulators said on Friday they would review whether to take action over Merck & Co Inc's and Schering-Plough Corp's popular cholesterol drug Vytorin after a study showed it was no better than a generic in preventing the build-up of fatty plaque.
457614
One of the nation&#39;s leading cardiovascular medical researchers has issued a call for less aggressive direct-to-consumer advertising and better safety assurances of medications in a special article posted online today by JAMA because of its relevance to
205695
The US Food and Drug Administration on Friday asked an outside group to review the way it monitors safety risks associated with medicines already on the market, such as Merck &amp; Co.
503537
The U.S. Food and Drug  Administration said on Tuesday it was creating an independent  drug safety board after the agency's monitoring of drugs  already in the marketplace was criticized amid the withdrawal  of arthritis drug Vioxx.
193641
Drug makers are being asked for the first time to put a comprehensive suicide assessment into clinical trials.
161932
The problems with Vioxx, taken off the market last week, raise questions about the Food and Drug Administration's safety review process. Observers say longer clinical trials should be required.
732137
U.S. health officials said on Friday they would review whether to take regulatory action over Merck & Co Inc and Schering-Plough's cholesterol medicine Vytorin following the drug's failure to work better than a generic drug in a study of plaque build-up in neck arteries.
166263
Nov. 18, 2004 -- An FDA scientist who says he was pressured by superiors not to warn the public about the cardiovascular risk of Vioxx urged lawmakers Thursday to create an independent safety office free of
458929
U.S. health officials said on Friday  they would review whether to take regulatory action over Merck  & Co Inc and Schering-Plough's cholesterol medicine Vytorin  following the drug's failure to work better than a generic drug  in a study of plaque build-up in neck arteries.
699575
The American Medical Association&#39;s policy-making board could make a decision today about supporting the safe importation of prescription drugs.
265006
U.S. lawmakers and health officials  are moving to give more independence to an office that reviews  drug safety, but some experts say ensuring medicines are  studied after they hit the market is more important than the  bureaucratic pecking order.
185982
The editors of the Journal of the American Medical Association (JAMA) are calling for an end to the US Food and Drug Administration&#39;s (FDA) role in post-market monitoring of the safety of drugs it approves.
272549
ROCKVILLE, Md.  - The U.S. Food and Drug  Administration said on Tuesday it was creating a new drug  safety board to improve the monitoring of medicines already in  the marketplace, a response to charges the agency has failed to  protect the public from dangerous side effects.